These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38553338)

  • 61. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
    Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
    Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute Variceal Bleeding: Does Octreotide Improve Outcomes in Patients with Different Functional Hepatic Reserve?
    Monreal-Robles R; Cortez-Hernández CA; González-González JA; Abraldes JG; Bosques-Padilla FJ; Silva-Ramos HN; García-Flores JA; Maldonado-Garza HJ
    Ann Hepatol; 2018; 17(1):125-133. PubMed ID: 29311398
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
    Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
    J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non-neoplastic thrombocytopenic disorders.
    Koh KR; Yamane T; Ohta K; Hino M; Takubo T; Tatsumi N
    Eur J Haematol; 1999 Nov; 63(5):295-301. PubMed ID: 10580560
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?
    Peck-Radosavljevic M; Zacherl J; Meng YG; Pidlich J; Lipinski E; Längle F; Steininger R; Mühlbacher F; Gangl A
    J Hepatol; 1997 Jul; 27(1):127-31. PubMed ID: 9252085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Comparison of an immature platelet fraction and reticulated platelet in liver cirrhosis].
    Kim HR; Park BR; Lee MK; Park AJ; Ahn JY
    Korean J Lab Med; 2007 Feb; 27(1):7-12. PubMed ID: 18094543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study.
    Ferreira Cardoso M; Alexandrino G; Carvalho E Branco J; Anapaz V; Carvalho R; Horta D; Martins A
    Gastroenterol Hepatol; 2019 May; 42(5):296-303. PubMed ID: 30772084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
    Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
    J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure.
    Perdigoto DN; Figueiredo P; Tomé L
    Ann Hepatol; 2019; 18(1):48-57. PubMed ID: 31113608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis.
    Shimodaira S; Ishida F; Ichikawa N; Tahara T; Kato T; Kodaira H; Ito T; Tanaka E; Sodeyama T; Kiyosawa K; Kitano K
    Thromb Haemost; 1996 Oct; 76(4):545-8. PubMed ID: 8902994
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis.
    Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Tsuji S; Kanda T; Moriyama M
    Biosci Trends; 2020 Nov; 14(5):368-375. PubMed ID: 32713867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
    Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
    Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Blunted thrombopoietin response to interferon alfa-induced thrombocytopenia during treatment for hepatitis C.
    Peck-Radosavljevic M; Wichlas M; Pidlich J; Sims P; Meng G; Zacherl J; Garg S; Datz C; Gangl A; Ferenci P
    Hepatology; 1998 Nov; 28(5):1424-9. PubMed ID: 9794931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Measurement of Spleen Stiffness With Acoustic Radiation Force Impulse Imaging Predicts Mortality and Hepatic Decompensation in Patients With Liver Cirrhosis.
    Takuma Y; Morimoto Y; Takabatake H; Toshikuni N; Tomokuni J; Sahara A; Matsueda K; Yamamoto H
    Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1782-1790.e4. PubMed ID: 28017842
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.
    Paternostro R; Kapzan L; Mandorfer M; Schwarzer R; Benedikt S; Viveiros A; Bauer D; Ferlitsch M; Zoller H; Trauner M; Ferlitsch A
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1619-1627. PubMed ID: 31972057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
    Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
    Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis.
    González-Ojeda A; Cervantes-Guevara G; Chávez-Sánchez M; Dávalos-Cobián C; Ornelas-Cázares S; Macías-Amezcua MD; Chávez-Tostado M; Ramírez-Campos KM; Ramírez-Arce Adel R; Fuentes-Orozco C
    World J Gastroenterol; 2014 Feb; 20(8):2079-84. PubMed ID: 24616574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    Verna EC; Morelli G; Terrault NA; Lok AS; Lim JK; Di Bisceglie AM; Zeuzem S; Landis CS; Kwo P; Hassan M; Manns MP; Vainorius M; Akushevich L; Nelson DR; Fried MW; Reddy KR
    J Hepatol; 2020 Sep; 73(3):540-548. PubMed ID: 32243960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.